|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 |
| (11) | Patento numeris | 3294326 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16725419.2 |
| Europos patento paraiškos padavimo data | 2016-05-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/060928 |
| Data | 2016-05-13 |
| (87) | Numeris | WO 2016/184822 |
| Data | 2016-11-24 |
| (30) | Numeris | Data | Šalis |
| PCT/EP2015/0009 | 2015-05-15 | WO |
| (72) |
FOTIN-MLECZEK, Mariola, DE
PROBST, Jochen, DE
|
| (73) |
CureVac AG,
Friedrich-Miescher-Stra e 15, 72076 Tübingen,
DE
|
| (54) | PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE MRNA CONSTRUCT |
| PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE MRNA CONSTRUCT |